Du, Ting
Song, Yan
Ray, Arghya
Chauhan, Dharminder
Anderson, Kenneth C.
Article History
Received: 19 November 2019
Revised: 29 April 2020
Accepted: 5 May 2020
First Online: 18 May 2020
Compliance with ethical standards
:
: KCA is on Advisory Board of Millenium-Takeda, Gilead, Janssen, Bristol Myers Squibb, and Sanofi Aventis, and is a Scientific Founder of Oncopep and C4 Therapeutics. DC is consultant to Stemline Therapeutic, Inc., and Equity owner in C4 Therapeutics. The remaining authors declare no conflict of interest.